Director, Learning & Development, EMEA

About the role

Scholar Rock is delivering muscle-targeted breakthroughs to transform the treatment of spinal muscular atrophy (SMA) and other rare neuromuscular diseases where muscle atrophy remains a critical unmet need. As a global leader in myostatin biology, a field focused on proteins that regulate muscle mass, the biopharmaceutical company is named for the visual resemblance of a scholar rock to protein structures. Our commitment to unlock fundamentally different treatment approaches is powered by broad application of a proprietary platform, which has developed novel monoclonal antibodies to modulate protein growth factors with extraordinary selectivity. Scholar Rock works every day to create new possibilities for patients through its highly innovative anti-myostatin program, including opportunities in additional rare neuromuscular diseases. Learn more about our neuromuscular franchise at ScholarRock.com and follow @ScholarRock on X and on LinkedIn. Summary of Position: We are seeking a strategic and results-driven Director, Learning & Development – EMEA to lead the development and execution of learning initiatives across EMEA markets. This role will focus on strengthening organizational capabilities across three key pillars: Clinical Acumen, Business Acumen, and Leadership & Soft Skills, ensuring employees have the knowledge, skills, and confidence to drive business performance. The Director will partner closely with regional leadership and global cross-functional teams to deliver a consistent global learning strategy while addressing local market needs. Position Responsibilities Clinical Acumen & Scientific Excellence Develop learning programs focused on disease state, mechanisms of action, clinical evidence, and therapeutic landscapes. Enhancing clinical story telling consistent with the approved product information (SmPC) and applicable codes of practice. Partner and coordinate with Commercial, Medical Affairs, Marketing, and other stakeholders to ensure scientific knowledge and learning standards are met. L&D drives design, delivery and measurement of training programs, and collaborates with functional leads on application in the field. Establish clinical competency assessments and certification programs, defined jointly with Medical Affairs and the Information Officer / Scientific Service, to ensure readiness and proficiency and to meet national requirements for medical sales representative qualification where applicable. Business Acumen & Commercial Excellence Build capabilities in market understanding, strategic thinking, business planning, and commercial execution. Develop learning initiatives that strengthen top-quality customer engagement, account management, and competitive understanding. Partner with regional leaders to identify capability gaps and align learning priorities with business objectives. Support product launches, commercial readiness, and continuous performance improvement. Leadership Development & Soft Skills Design programs focused on emotional intelligence, communication, effective questioning, active listening, and influencing skills. Strengthen leadership capabilities in coaching, feedback, accountability, and team development. Foster collaboration, adaptability, and a culture of continuous learning. Integrate behavioral development into clinical and commercial learning initiatives. Global Alignment & Learning Effectiveness Translate the Global L&D strategy into a regional learning roadmap aligned with European business priorities. Ensure consistency in learning objectives, content, competency standards, and execution across markets. Adapt learning experiences to local market requirements while maintaining global alignment. Implement learning assessments, certification, and performance measurement to demonstrate impact. In line with Company policies, leverage Artificial Intelligence and digital learning platforms and innovative methodologies to enhance learning effectivene

Skills